Back to discover
Disease

Coronary Restenosis

Late-stage therapeutic developmentEmerging research
MeSHCoronary Restenosis
1
Publications
9
Clinical trials
2002
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

7 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
9
All trials
0
Active
4
Late-stage
6
Completed
Late-stage studies

A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Impact of Oral Sirolimus on Restenosis Prevention in Patients With In-Stent Restenosis.

Phase 4 · Completed · Deutsches Herzzentrum Muenchen

XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)

Phase 4 · Completed · Abbott Medical Devices

Phase 4 Study of Randomized Comparison Among Oral Rapamycin Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions.

Phase 4 · Completed · Centro de estudios en Cardiologia Intervencionista

Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention

Phase 4 · Completed · Lantheus Medical Imaging
Recently completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)

Phase 4 · Completed · Abbott Medical Devices

A Pilot Study to Evaluate the Efficacy and Safety of Different Bindarit Dosages in Preventing Stent Restenosis

Phase 2 · Completed · Aziende Chimiche Riunite Angelini Francesco S.p.A

A Phase I/II Safety Trial of Intracoronary Administration of Systemic Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis

Phase 1/2 · Completed · Celgene Corporation

Phase 4 Study of Randomized Comparison Among Oral Rapamycin Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions.

Phase 4 · Completed · Centro de estudios en Cardiologia Intervencionista

Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention

Phase 4 · Completed · Lantheus Medical Imaging

A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Impact of Oral Sirolimus on Restenosis Prevention in Patients With In-Stent Restenosis.

Phase 4 · Completed · Deutsches Herzzentrum Muenchen

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

The New England journal of medicine · 2002 · 2,660 cites
Recent publications

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

The New England journal of medicine · 2002 · 2,660 cites
Major themes1
  • Stents1
Leading journals1
  • The New England journal of medicine1
Leading researchers8
  • Ban Hayashi E1
  • Barragan P1
  • Colombo A1
  • Fajadet J1
  • Falotico R1
  • Guagliumi G1
  • Molnàr F1
  • Morice MC1
Affiliations (unnormalised)1
  • Institut Cardiovasculaire Paris Sud1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Identifiers
MeSHCoronary Restenosis
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.